A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

  • Tell a FriendPrint

The purpose of this study is to assess the comfort of a glaucoma therapy in patients with open-angle glaucoma or ocular...

Brief Summary

Official Title: “A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension”

The purpose of this study is to assess the comfort of a glaucoma therapy in patients with open-angle glaucoma or ocular hypertension

  • Study Type: Interventional
  • Study Design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Intervention(s) in this Clinical Trial

  • Drug: Brinzolamide/Timolol

Outcome Measures for this Clinical Trial

Primary Measures

  • Ocular discomfort

Criteria for Participation in this Clinical Trial

Inclusion Criteria:

  • Adults of either sex and any race diagnosed with open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component)

Exclusion Criteria:

  • Under 18

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Clinical Trial Investigator Information

Lead Investigator: Alcon Research Industry

Overall Clinical Trial Officials and Contacts

Julia White Study Director Study Director  

Additional Information

Information obtained from ClinicalTrials.gov on February 12, 2012

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00326092

Study ID Number: C-05-49

ClinicalTrials.gov Identifier: NCT00326092

Health Authority: United States: Food and Drug Administration

  • Tell a FriendPrint

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00326092